SCHEMBL14847366

SCHEMBL14847366

c1ccc(-c2ccc(-c3cnn[nH]3)cc2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 2/20 0.46
CYP2A6 P11509 1/20 0.44
CYP1A2 P05177 2/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
CCR1 P32246 1/20 0.43
CCR5 P51681 1/20 0.43
CCR8 P51685 1/20 0.43
METAP1 P53582 1/20 0.43
BLM P54132 1/20 0.43
HIF1A Q16665 1/20 0.43
DOHH Q9BU89 1/20 0.43
P4HTM Q9NXG6 1/20 0.43
AURKA O14965 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
TGFBR1 P36897 6/20 0.41
CYP2D6 P10635 1/20 0.41
CYP19A1 P11511 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL503719 0.85 KDM4E (0.50) NPY5RCYP2A6CYP1A2KDM4ELMNA
SCHEMBL13411815 0.79 POLB (0.33) POLBCYP3A4
SCHEMBL29445989 0.78 CYP2D6 (0.43) CYP2D6MAPK14
SCHEMBL17283676 0.77 SCN4A (0.43) NPY5RPOLBHPGDSCYP3A4NPC1
SCHEMBL10018 0.77 SCN4A (0.46) NPY5RLMNAPOLBHPGDSCYP3A4
SCHEMBL30989132 0.77 KDM4E (0.72) CYP2A6CYP1A2KDM4ELMNAPOLB
SCHEMBL30989133 0.77 KDM4E (0.72) CYP2A6CYP1A2KDM4ELMNAPOLB
SCHEMBL1566968 0.77 KDM4E (0.72) CYP2A6CYP1A2KDM4ELMNAPOLB
SCHEMBL13458076 0.74 KDM4E (0.68) CYP2A6CYP1A2KDM4ELMNAPOLB
SCHEMBL29984274 0.74 KDM4E (0.68) CYP2A6CYP1A2KDM4ELMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1919881-B1 1, 2, 3 -TRIAZOLES INHIBITORS OF TUBULIN POLYMERIZATION FOR THE TREATMENT OF POLIFERATIVE DISORDERS SYNTA PHARMACEUTICALS CORP (US) 2013-04-10 EP disclosed